Literature DB >> 11737824

The polarity of the retinal pigment epithelium.

A D Marmorstein1.   

Abstract

The diversity of epithelia in the body permits a multitude of organ-specific functions. One of the foremost examples of this is the retinal pigment epithelium. Located between the photoreceptors of the retina and their principal blood supply, the choriocapillaris, the retinal pigment epithelium is critical for the survival and function of retinal photoreceptors. To serve this purpose, the retinal pigment epithelium cell has adapted the classic Golgi-to-cell-surface targeting pathways first described in such prototypic epithelial cell models as the Madin-Darby canine kidney cell, to arrive at a unique distribution of membrane and secreted proteins. More recent data suggest that the retinal pigment epithelium also takes advantage of its inherent asymmetry to augment the classical pathways of Golgi-to-cell-surface traffic. As retinal pigment epithelium transplants and gene therapy represent potential cures for retinal degenerative diseases, understanding the basis of the unique polarity properties of retinal pigment epithelium cells will be a critical issue for the development of future therapies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11737824     DOI: 10.1034/j.1600-0854.2001.21202.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  48 in total

1.  The basolateral targeting signal of CD147 (EMMPRIN) consists of a single leucine and is not recognized by retinal pigment epithelium.

Authors:  Ami A Deora; Diego Gravotta; Geri Kreitzer; Jane Hu; Dean Bok; Enrique Rodriguez-Boulan
Journal:  Mol Biol Cell       Date:  2004-06-23       Impact factor: 4.138

Review 2.  The retinal pigment epithelium in health and disease.

Authors:  J R Sparrow; D Hicks; C P Hamel
Journal:  Curr Mol Med       Date:  2010-12       Impact factor: 2.222

3.  Leukemia inhibitory factor coordinates the down-regulation of the visual cycle in the retina and retinal-pigmented epithelium.

Authors:  Ana J Chucair-Elliott; Michael H Elliott; Jiangang Wang; Gennadiy P Moiseyev; Jian-Xing Ma; Luis E Politi; Nora P Rotstein; Shizuo Akira; Satoshi Uematsu; John D Ash
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

4.  Identification of zebrafish insertional mutants with defects in visual system development and function.

Authors:  Jeffrey M Gross; Brian D Perkins; Adam Amsterdam; Ana Egaña; Tristan Darland; Jonathan I Matsui; Salvatore Sciascia; Nancy Hopkins; John E Dowling
Journal:  Genetics       Date:  2005-02-16       Impact factor: 4.562

5.  Tetraspanin CD81 is required for the alpha v beta5-integrin-dependent particle-binding step of RPE phagocytosis.

Authors:  Yongen Chang; Silvia C Finnemann
Journal:  J Cell Sci       Date:  2007-08-07       Impact factor: 5.285

6.  Control of chemokine gradients by the retinal pigment epithelium.

Authors:  Guangpu Shi; Arvydas Maminishkis; Tina Banzon; Stephen Jalickee; Rong Li; Jeffrey Hammer; Sheldon S Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-30       Impact factor: 4.799

7.  Relationship of stokes radius to the rate of diffusion across Bruch's membrane.

Authors:  Astrid Zayas-Santiago; Alan D Marmorstein; Lihua Y Marmorstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-01       Impact factor: 4.799

8.  Revisiting the role of Dcc in visual system development with a novel eye clearing method.

Authors:  Robin J Vigouroux; Quénol Cesar; Alain Chédotal; Kim Tuyen Nguyen-Ba-Charvet
Journal:  Elife       Date:  2020-02-25       Impact factor: 8.140

Review 9.  The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier--implications for the pathogenesis of diabetic retinopathy.

Authors:  Rafael Simó; Marta Villarroel; Lídia Corraliza; Cristina Hernández; Marta Garcia-Ramírez
Journal:  J Biomed Biotechnol       Date:  2010-02-17

10.  Localizations of visual cycle components in retinal pigment epithelium.

Authors:  Jing Huang; Daniel E Possin; John C Saari
Journal:  Mol Vis       Date:  2009-01-26       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.